Details

Résumé de recherche du RIEM : Le bévacizumab pour injection intravitréenne a-t-il un bon profil d’innocuité dans le traitement des causes courantes de cécité? - IRSC

Metadata and links for an archived snapshot.

Source
Canadian Institutes of Health Research
Date
Feb 13, 2026 · edition #8
Timestamp
2026-02-13T04:05:01.185Z
Language
fr
ID
1027837
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview